Levetiracetam Tarbis (Levetiracetam)

Levetiracetam exerts its effect by binding to the synaptic vesicle protein SV2A, which plays a key role in neurotransmitter release. This binding modulates calcium‑dependent exocytosis, stabilizing synaptic activity and decreasing excessive neuronal firing that can trigger seizures.

The appropriate dose of levetiracetam is individualized by the prescribing clinician based on factors such as the patient’s age, weight, renal function, seizure type, and response to therapy. Dosage adjustments may be required for patients with impaired kidney function.

The safety of levetiracetam in pregnancy and lactation has not been definitively established. It is classified as pregnancy category unknown, so it should be used only when the potential benefit justifies any potential risk to the fetus. Breastfeeding mothers should discuss risks with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Levetiracetam Tarbis. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam is often compared with other antiepileptics such as carbamazepine or valproic acid. Unlike many older agents, it has a relatively favorable drug‑interaction profile and does not require routine therapeutic drug monitoring. However, individual response and tolerability vary, so clinicians choose the agent best suited to the patient’s seizure type and comorbidities.

Levetiracetam Tarbis should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Levetiracetam Tarbis is taken orally, usually with or without food, as directed by the prescribing physician. The tablets are swallowed whole with a glass of water. Patients should follow the dosing schedule provided by their healthcare professional and not alter the regimen without medical advice.

Serious adverse reactions, though uncommon, include severe skin reactions (e.g., Stevens‑Johnson syndrome), significant mood changes such as depression or suicidal thoughts, blood disorders like neutropenia, and rare multi‑organ hypersensitivity. Patients should seek immediate medical attention if they notice rash, mood alterations, unexplained bruising or signs of infection.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, as dose adjustment is required, and for those with a history of psychiatric disorders, given the potential for mood changes.